CLMP Is a Tumor Suppressor That Determines All-Trans Retinoic Acid Response in Colorectal Cancer

Researchers demonstrated that CAR-like membrane protein (CLMP) was rarely mutated but significantly decreased in colorectal cancer (CRC) patients, and its deficiency accelerated CRC tumorigenesis, growth, and resistance to all-trans retinoic acid.